Medigene AG Medigene AG

Medigene AG

MDG1

Hisse Senetlerindeki Sıralama #35299
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Hisse Fiyatı
$0.14942078
Son senkronizasyon: 2025-05-15
Piyasa Değeri
$3.86M
Değişim (1 gün)
0.10%
Değişim (1 yıl)
47.84%
Ülke
DE
Ticaret Medigene AG (MDG1)

Kategori

Healthcare
Medigene AG (MDG1) için hisse bölünme geçmişi
Medigene AG hissesi (sembol: MDG1) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Oct 21, 2026 tarihinde gerçekleşmiştir.
Oct 21, 2026 tarihinden önce alınan bir MDG1 hissesi bugün 0 MDG1 hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH